Exact Mass: 387.18343400000003

Exact Mass Matches: 387.18343400000003

Found 115 metabolites which its exact mass value is equals to given mass value 387.18343400000003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Terazosin

1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine

C19H25N5O4 (387.190645)


Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls. G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents

   

Pcera-1

[1-(3-Methoxyphenyl)-1-(octanoylamino)propan-2-yl] dihydrogen phosphate

C18H30NO6P (387.18106500000005)


   

(-)-14-O-Malonylindolactam-V

(-)-14-O-Malonylindolactam-V

C20H25N3O5 (387.179412)


   

31F508a1

Bioxalomycin alpha1

C20H25N3O5 (387.179412)


   

O-Methyltetradehydrotriphyophylline

(+)-O-Methyltetradehydrotriphyophylline

C25H25NO3 (387.18343400000003)


   

7beta-Hydroxycatuabine E

(+)-7beta-Hydroxycatuabine E

C20H25N3O5 (387.179412)


   
   

2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinicacid

2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinicacid

C20H25N3O5 (387.179412)


   
   
   
   

CAY10583

4-[[(1-oxopentyl)phenylamino]methyl]-[1,1-biphenyl]-2-carboxylic acid

C25H25NO3 (387.18343400000003)


   
   

terazosin

terazosin

C19H25N5O4 (387.190645)


G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents

   

1,N6-4-Oxo-(2E)-nonenal-deoxyadenosine

1,N6-4-Oxo-(2E)-nonenal-deoxyadenosine

C19H25N5O4 (387.190645)


   

Ala Asn Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Ala Asn Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Ala Pro Asn Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Ala Pro Ser Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Ala Ser Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Ala Ser Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Gly Asn Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C15H25N5O7 (387.17539)


   

Gly Asn Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Gly Pro Asn Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C15H25N5O7 (387.17539)


   

Gly Pro Gln Ser

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Gly Pro Ser Gln

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C15H25N5O7 (387.17539)


   

Gly Pro Thr Asn

(2S)-2-[(2S,3R)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Gly Gln Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Gly Gln Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Gly Ser Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C15H25N5O7 (387.17539)


   

Gly Ser Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Gly Thr Asn Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Gly Thr Pro Asn

(2S)-2-{[(2S)-1-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Asn Ala Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Asn Ala Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Asn Gly Pro Thr

(2S,3R)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C15H25N5O7 (387.17539)


   

Asn Gly Thr Pro

(2S)-1-[(2S,3R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Asn Pro Ala Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Asn Pro Gly Thr

(2S,3R)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxybutanoic acid

C15H25N5O7 (387.17539)


   

Asn Pro Ser Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]propanoic acid

C15H25N5O7 (387.17539)


   

Asn Pro Thr Gly

2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]acetic acid

C15H25N5O7 (387.17539)


   

Asn Ser Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Asn Ser Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C15H25N5O7 (387.17539)


   

Asn Thr Gly Pro

(2S)-1-{2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Asn Thr Pro Gly

2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C15H25N5O7 (387.17539)


   

Pro Ala Asn Ser

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Pro Ala Ser Asn

(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C15H25N5O7 (387.17539)


   

Pro Gly Asn Thr

(2S,3R)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-hydroxybutanoic acid

C15H25N5O7 (387.17539)


   

Pro Gly Gln Ser

(2S)-2-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Pro Gly Ser Gln

(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]butanoic acid

C15H25N5O7 (387.17539)


   

Pro Gly Thr Asn

(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]propanoic acid

C15H25N5O7 (387.17539)


   

Pro Asn Ala Ser

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Pro Asn Gly Thr

(2S,3R)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-hydroxybutanoic acid

C15H25N5O7 (387.17539)


   

Pro Asn Ser Ala

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]propanoic acid

C15H25N5O7 (387.17539)


   

Pro Asn Thr Gly

2-[(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxybutanamido]acetic acid

C15H25N5O7 (387.17539)


   

Pro Gln Gly Ser

(2S)-2-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Pro Gln Ser Gly

2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxypropanamido]acetic acid

C15H25N5O7 (387.17539)


   

Pro Ser Ala Asn

(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C15H25N5O7 (387.17539)


   

Pro Ser Gly Gln

(2S)-4-carbamoyl-2-{2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}butanoic acid

C15H25N5O7 (387.17539)


   

Pro Ser Asn Ala

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C15H25N5O7 (387.17539)


   

Pro Ser Gln Gly

2-[(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]acetic acid

C15H25N5O7 (387.17539)


   

Pro Thr Gly Asn

(2S)-3-carbamoyl-2-{2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}propanoic acid

C15H25N5O7 (387.17539)


   

Pro Thr Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]acetic acid

C15H25N5O7 (387.17539)


   

Gln Gly Pro Ser

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Gln Gly Ser Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Gln Pro Gly Ser

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxypropanoic acid

C15H25N5O7 (387.17539)


   

Gln Pro Ser Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]acetic acid

C15H25N5O7 (387.17539)


   

Gln Ser Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Gln Ser Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C15H25N5O7 (387.17539)


   

Ser Ala Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Ser Ala Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Ser Gly Pro Gln

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-hydroxypropanamido]acetyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C15H25N5O7 (387.17539)


   

Ser Gly Gln Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Ser Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Ser Asn Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C15H25N5O7 (387.17539)


   

Ser Pro Ala Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Ser Pro Gly Gln

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-carbamoylbutanoic acid

C15H25N5O7 (387.17539)


   

Ser Pro Asn Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]propanoic acid

C15H25N5O7 (387.17539)


   

Ser Pro Gln Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]acetic acid

C15H25N5O7 (387.17539)


   

Ser Gln Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Ser Gln Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C15H25N5O7 (387.17539)


   

Thr Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Thr Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Thr Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H25N5O7 (387.17539)


   

Thr Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C15H25N5O7 (387.17539)


   

Thr Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

C15H25N5O7 (387.17539)


   

Thr Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

C15H25N5O7 (387.17539)


   
   

N-(hydroxymethyl)-2-methylprop-2-enamide,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid

N-(hydroxymethyl)-2-methylprop-2-enamide,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid

C18H29NO8 (387.1893074)


   

Ethyl 2-(acetylamino)-3-[3,5-diamino-4-(4-methoxyphenoxy)phenyl]propanoate

Ethyl 2-(acetylamino)-3-[3,5-diamino-4-(4-methoxyphenoxy)phenyl]propanoate

C20H25N3O5 (387.179412)


   

(4S)-tert-Butyl-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole

(4S)-tert-Butyl-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole

C25H26NOP (387.17519160000006)


   

Dipivefrin HCl

Dipivefrin hydrochloride

C19H30ClNO5 (387.18124000000006)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent

   

4-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-1-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole

4-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-1-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole

C21H21N7O (387.1807496)


   

4-[4-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-1-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole

4-[4-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-1-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole

C21H21N7O (387.1807496)


   

1-[4-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-4-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole

1-[4-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-4-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole

C21H21N7O (387.1807496)


   

2-{4-[(N-phenylpentanamido)methyl]phenyl}benzoic acid

2-{4-[(N-phenylpentanamido)methyl]phenyl}benzoic acid

C25H25NO3 (387.18343400000003)


   

(2E,4E)-5-[(1R,7S,8S,9R)-7-acetyloxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate

(2E,4E)-5-[(1R,7S,8S,9R)-7-acetyloxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate

C22H27O6- (387.1807542)


   

2-Amino-7-[2-[2-(2-amino-6-oxo-1,9-dihydropurin-7-ium-7-yl)ethyl-methylamino]ethyl]-1,9-dihydropurin-7-ium-6-one

2-Amino-7-[2-[2-(2-amino-6-oxo-1,9-dihydropurin-7-ium-7-yl)ethyl-methylamino]ethyl]-1,9-dihydropurin-7-ium-6-one

C15H21N11O2+2 (387.1879606)


   

3-fluoro-N-[1-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-4-piperidinyl]benzamide

3-fluoro-N-[1-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-4-piperidinyl]benzamide

C21H23F2N3O2 (387.17582419999997)


   

1-Cyclohexyl-5-[1-(2,4-dimethoxyanilino)ethylidene]-1,3-diazinane-2,4,6-trione

1-Cyclohexyl-5-[1-(2,4-dimethoxyanilino)ethylidene]-1,3-diazinane-2,4,6-trione

C20H25N3O5 (387.179412)


   

6-Amino-5-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-1-oxoethyl]-1,3-dimethylpyrimidine-2,4-dione

6-Amino-5-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-1-oxoethyl]-1,3-dimethylpyrimidine-2,4-dione

C19H25N5O4 (387.190645)


   

(4E,8E)-10-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate

(4E,8E)-10-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate

C22H27O6- (387.1807542)


   

1-[(1S,5R)-7-[4-(4-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-2-pyridin-4-ylethanone

1-[(1S,5R)-7-[4-(4-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-2-pyridin-4-ylethanone

C24H22FN3O (387.1746814)


   
   

Cbz-lysine thiobenzyl ester(1+)

Cbz-lysine thiobenzyl ester(1+)

C21H27N2O3S+ (387.1742292)


   
   

(R)-Terazosin

(R)-Terazosin

C19H25N5O4 (387.190645)


(R)-Terazosin is an active R-enantiomer of Terazosin. (R)-Terazosin is a potent α1-adrenoceptor antagonist with Ki values of 6.51 nM, 1.01 nM and 1.97 nM for α1a, α1b and α1d-adrenoceptor, respectively[1].

   

(S)-Terazosin

(S)-Terazosin

C19H25N5O4 (387.190645)


(S)-Terazosin is an active S-enantiomer of Terazosin. (S)-Terazosin is a potent and high-affinity α-adrenoceptor antagonist with Ki values of 3.91 nM, 0.79 nM and 1.16 nM for α1a, α1b and α1d-adrenoceptor, respectively. (S)-Terazosin also has high-affinity for α2a, α2B and α2c-adrenoceptor with Ki values of 729 nM, 3.5 nM and 46.4 nM, respectively[1].

   

9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

C20H25N3O5 (387.179412)


   

(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

C20H25N3O5 (387.179412)


   

(19s,21s)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

(19s,21s)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

C20H25N3O5 (387.179412)


   

(1r,3r,6r,13r,18r,19s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

(1r,3r,6r,13r,18r,19s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol

C20H25N3O5 (387.179412)


   

3-{[(10s,13s)-11-hydroxy-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-13-yl]methoxy}-3-oxopropanoic acid

3-{[(10s,13s)-11-hydroxy-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-13-yl]methoxy}-3-oxopropanoic acid

C20H25N3O5 (387.179412)


   

3-({11-hydroxy-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-13-yl}methoxy)-3-oxopropanoic acid

3-({11-hydroxy-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-13-yl}methoxy)-3-oxopropanoic acid

C20H25N3O5 (387.179412)


   

(1s,3r,5r,6s,7r)-6-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

(1s,3r,5r,6s,7r)-6-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

C20H25N3O5 (387.179412)